Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.

This publication has 102 references indexed in Scilit:

• Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes
  The American Journal of Cardiology, 1989
• Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
  British Journal of Surgery, 1988
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
  The Journal of Clinical Pharmacology, 1988
• Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  Biochemical and Biophysical Research Communications, 1983
• The effects of phospholipid and factor Va on the inhibition of Factor Xa by antithrombin III
  Biochemical and Biophysical Research Communications, 1979
• Heparin therapy: A randomized prospective study
  American Heart Journal, 1979
• Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin
  FEBS Letters, 1976
• The separation of active and inactive forms of heparin
  Biochemical and Biophysical Research Communications, 1976